N-of-One to Pipeline: The Future of Personalized Rare Disease Therapies

Ahead of the Curve: Lee Hood on Innovation & Genomics

What does it take to see the next wave before it arrives? Michelle Chen, Form Bio's CEO, sits down with systems biology pioneer Dr. Lee Hood at SynBioBeta to discuss the bold scientific bets that shaped modern biotechnology, from automated DNA sequencing to the Human Genome Project and personalized health. The conversation dives into Dr. Hood’s “4P Medicine” framework—predictive, preventive, personalized, and participatory—and how emerging technologies could shift healthcare from sick care to true wellness.

N-of-One to Pipeline: The Future of Personalized Rare Disease Therapies

Michelle Chen, CEO at Form Bio, sits down with Richard Horgan, Founder and CEO of the Cure Rare Disease Foundation, to share a deeply personal story that became a mission, accelerating cell and gene therapy development for ultra-rare diseases.